These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32331428)

  • 1. Lysophosphatidylcholine Containing Anisic Acid Is Able to Stimulate Insulin Secretion Targeting G Protein Coupled Receptors.
    Drzazga A; Okulus M; Rychlicka M; Biegała Ł; Gliszczyńska A; Gendaszewska-Darmach E
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32331428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprenoid Derivatives of Lysophosphatidylcholines Enhance Insulin and GLP-1 Secretion through Lipid-Binding GPCRs.
    Drzazga A; Kamińska D; Gliszczyńska A; Gendaszewska-Darmach E
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine and its phosphorothioate analogues potentiate insulin secretion via GPR40 (FFAR1), GPR55 and GPR119 receptors in a different manner.
    Drzazga A; Kristinsson H; Sałaga M; Zatorski H; Koziołkiewicz M; Gendaszewska-Darmach E; Bergsten P
    Mol Cell Endocrinol; 2018 Sep; 472():117-125. PubMed ID: 29225068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of βTC3 and MIN6 Pseudoislets Changes the Expression Pattern of Gpr40, Gpr55, and Gpr119 Receptors and Improves Lysophosphatidylcholines-Potentiated Glucose-Stimulated Insulin Secretion.
    Drzazga A; Cichońska E; Koziołkiewicz M; Gendaszewska-Darmach E
    Cells; 2020 Sep; 9(9):. PubMed ID: 32917053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from βTC-3 pancreatic cells: Evaluation of structure-dependent biological activity.
    Drzazga A; Sowińska A; Krzemińska A; Okruszek A; Paneth P; Koziołkiewicz M; Gendaszewska-Darmach E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):91-103. PubMed ID: 29079451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.
    Soga T; Ohishi T; Matsui T; Saito T; Matsumoto M; Takasaki J; Matsumoto S; Kamohara M; Hiyama H; Yoshida S; Momose K; Ueda Y; Matsushime H; Kobori M; Furuichi K
    Biochem Biophys Res Commun; 2005 Jan; 326(4):744-51. PubMed ID: 15607732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein coupled receptor 55 agonists increase insulin secretion through inositol trisphosphate-mediated calcium release in pancreatic β-cells.
    Vong CT; Tseng HHL; Kwan YW; Lee SM; Hoi MPM
    Eur J Pharmacol; 2019 Jul; 854():372-379. PubMed ID: 31054273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
    Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S
    Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfur- and acyl chain-dependent influence of 2-methoxy-lysophosphatidylcholine analogues on β pancreatic cells.
    Drzazga A; Ciesielska A; Gendaszewska-Darmach E
    Curr Top Med Chem; 2015; 15(23):2395-405. PubMed ID: 26088355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of novel small molecule agonists of G protein-coupled receptor 119.
    Zhang SY; Li J; Xie X
    Acta Pharmacol Sin; 2014 Apr; 35(4):540-8. PubMed ID: 24681896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
    Yoshida S; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion.
    Suckow AT; Polidori D; Yan W; Chon S; Ma JY; Leonard J; Briscoe CP
    J Biol Chem; 2014 May; 289(22):15751-63. PubMed ID: 24742677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of Glucose-stimulated Insulin Secretion by the GPR40-PLC-TRPC Pathway in Pancreatic β-Cells.
    Yamada H; Yoshida M; Ito K; Dezaki K; Yada T; Ishikawa SE; Kakei M
    Sci Rep; 2016 May; 6():25912. PubMed ID: 27180622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free fatty acids increase cytosolic free calcium and stimulate insulin secretion from beta-cells through activation of GPR40.
    Schnell S; Schaefer M; Schöfl C
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):173-80. PubMed ID: 17101212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice.
    McKillop AM; Moran BM; Abdel-Wahab YH; Flatt PR
    Br J Pharmacol; 2013 Nov; 170(5):978-90. PubMed ID: 23992544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways.
    Lan H; Lin HV; Wang CF; Wright MJ; Xu S; Kang L; Juhl K; Hedrick JA; Kowalski TJ
    Br J Pharmacol; 2012 Apr; 165(8):2799-807. PubMed ID: 22029751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding.
    Kebede M; Alquier T; Latour MG; Semache M; Tremblay C; Poitout V
    Diabetes; 2008 Sep; 57(9):2432-7. PubMed ID: 18559658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
    Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K
    J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion.
    El-Azzouny M; Evans CR; Treutelaar MK; Kennedy RT; Burant CF
    J Biol Chem; 2014 May; 289(19):13575-88. PubMed ID: 24675078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between GPR40 and lipotoxicity of the pancreatic β-cells as well as the effect of pioglitazone.
    Wu P; Yang L; Shen X
    Biochem Biophys Res Commun; 2010 Dec; 403(1):36-9. PubMed ID: 21036144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.